Astrazeneca Pharma India Ltd Quarterly Result
Astrazeneca Pharma India Ltd
NSE: ASTRAZEN
Net Profit - Last Quarter
Astrazeneca Pharma India Ltd Quarterly Results Key Highlights
- The revenue of Astrazeneca Pharma India Ltd for the Mar '26 is ₹ 584.56 crore as compare to the Dec '25 revenue of ₹ 618.18 crore.
- This represent the decline of -5.44% The ebitda of Astrazeneca Pharma India Ltd for the Mar '26 is ₹ 65.78 crore as compare to the Dec '25 ebitda of ₹ 51.44 crore.
- This represent the growth of 27.88% The net profit of Astrazeneca Pharma India Ltd for the Mar '26 is ₹ 44.88 crore as compare to the Dec '25 net profit of ₹ 32.59 crore.
- This represent the growth of 37.71%.
Astrazeneca Pharma India Ltd Quarterly Results Analysis
Market Price of Astrazeneca Pharma India Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 10 Jun 2026 | 8304.35 |
| 09 Jun 2026 | 8457.45 |
| 08 Jun 2026 | 8383.4 |
| 05 Jun 2026 | 8598.6 |
| 04 Jun 2026 | 8497.05 |
| 03 Jun 2026 | 8548.3 |
| 02 Jun 2026 | 8719.05 |
| 01 Jun 2026 | 8724.25 |
| 29 May 2026 | 8671.45 |
| 27 May 2026 | 8655.3 |
Historical Revenue of Astrazeneca Pharma India Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Astrazeneca Pharma India Ltd
Historical EBITDA of Astrazeneca Pharma India Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Astrazeneca Pharma India Ltd
Historical Net Profit of Astrazeneca Pharma India Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Astrazeneca Pharma India Ltd
Astrazeneca Pharma India Ltd News Hub
AstraZeneca slumps on recording dismal Q1 performance
Revenue from operations jumped 31.15% year on year (YoY) to Rs 387.52 crore in the quarter ended 30
Read more
08 Aug 24
Astrazeneca Pharma India reports standalone net loss of Rs 11.79 crore in the June 2024 quarter
Net loss of Astrazeneca Pharma India reported to Rs 11.79 crore in the quarter ended June 2024 as ag
Read more
08 Aug 24
Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions
Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed by IMFINZI
Read more
24 Sept 24
Astrazeneca Pharma India Ltd leads gainers in 'A' group
Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and National Alumini
Read more
24 Sept 24
Document
Annual Reports
Annual Report 2024
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
About Astrazeneca Pharma India Ltd
- AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979.
- The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company.
- The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.
- Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company.
FAQs for Quarterly Results of Astrazeneca Pharma India Ltd
What key financial metrics are included in Astrazeneca Pharma India Ltd's quarterly results?
When does Astrazeneca Pharma India Ltd announce its quarterly results?
How does Astrazeneca Pharma India Ltd's quarterly performance impact its stock price?
What is the impact of Astrazeneca Pharma India Ltd's quarterly results on dividends?
Are there any special announcements usually made during Astrazeneca Pharma India Ltd's quarterly results?
